Department of Pharmaceutical Chemistry and Drug Control, Faculty of Pharmacy in Hradec Králové, Charles University in Prague, Heyrovského 1203, 500 05 Hradec Králové, Czech Republic.
J Chromatogr A. 2011 Jan 21;1218(3):416-26. doi: 10.1016/j.chroma.2010.11.050. Epub 2010 Nov 27.
This paper presents a systematic study of the retention behavior of a model bisdioxopiperazine drug, dexrazoxane (DEX) and its three polar metabolites (two single open-ring intermediates-B and C and an EDTA-like active compound ADR-925) on different stationary phases intended for hydrophilic interaction liquid chromatography (HILIC). The main aim was to estimate advantages and limitations of HILIC in the simultaneous analysis of a moderately lipophilic parent drug and its highly polar metabolites, including positional isomers, under MS compatible conditions. The study involved two bare silica columns (Ascentic Express HILIC, Atlantis HILIC) and two stationary phases with distinct zwitterionic properties (Obelisc N and ZIC HILIC). The chromatographic conditions (mobile phase strength and pH, column temperature) were systematically modified to assess their impact on retention and separation of the studied compounds. It was found that the bare silica phases were unable to separate the positional isomers (intermediates B and C), whereas both columns with zwitterionic properties (Obelisc N and ZIC HILIC) were able to separate these structurally very similar compounds. However, only ZIC HILIC phase allowed appropriate separation of DEX and all its metabolites to a base line within a single run. A mobile phase composed of a mixture of ammonium formate (0.5 mM) and acetonitrile (25:75, v/v) was suggested as optimal for the simultaneous analysis of DEX and its metabolites on ZIC HILIC. Thereafter, HILIC-LC-MS analysis of DEX and all its metabolites was performed for the first time to obtain basic data about the applicability of the suggested chromatographic conditions. Hence, this study demonstrates that HILIC could be a viable solution for the challenging analysis of moderately polar parent drug along with its highly polar metabolites including the ability to separate structurally very similar compounds, such as positional isomers.
本文对模型双二氧杂环戊二酮药物地塞米松(DEX)及其三种极性代谢物(两种单开环中间体 B 和 C 以及一种 EDTA 样活性化合物 ADR-925)在不同用于亲水相互作用液相色谱(HILIC)的固定相上的保留行为进行了系统研究。主要目的是在 MS 兼容条件下,评估 HILIC 同时分析中度亲脂性母体药物及其高度极性代谢物(包括位置异构体)的优缺点。该研究涉及两种裸硅胶柱(Ascentic Express HILIC、Atlantis HILIC)和两种具有不同两性离子特性的固定相(Obelisc N 和 ZIC HILIC)。系统地修改了色谱条件(流动相强度和 pH 值、柱温),以评估它们对研究化合物保留和分离的影响。结果发现,裸硅胶相无法分离位置异构体(中间体 B 和 C),而具有两性离子特性的两种柱(Obelisc N 和 ZIC HILIC)都能够分离这些结构非常相似的化合物。然而,只有 ZIC HILIC 相允许在单个运行中适当分离 DEX 和其所有代谢物至基线。建议使用包含甲酸铵(0.5 mM)和乙腈(25:75,v/v)的混合物作为流动相,以优化 ZIC HILIC 上同时分析 DEX 和其代谢物的条件。此后,首次进行了 DEX 和其所有代谢物的 HILIC-LC-MS 分析,以获得有关建议色谱条件适用性的基本数据。因此,本研究表明,HILIC 可能是分析中度极性母体药物及其高度极性代谢物(包括分离结构非常相似的化合物的能力,如位置异构体)的可行解决方案。